Anti-TNFα therapy early improves hemodynamics in local intestinal and extraintestinal circulations in active Crohn's disease

Journal of Crohn's and Colitis

Volumn 7, Issue 6, 2013, Pages 451-459

  Bonnin, Philippe ^a   Coelho, Jessica ^a   Pocard, Marc ^a   Levy, Bernard I ^a   Marteau, Philippe ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Anti TNF ; ; Crohn's disease; ; Retrobulbar arteries; Superior mesenteric artery; ; Ultrasound imaging;

Indexed keywords

ADALIMUMAB; C REACTIVE PROTEIN; FIBRINOGEN; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ARTERIAL PRESSURE; ARTICLE; BLOOD FLOW VELOCITY; CILIARY ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ECHOGRAPHY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMODYNAMICS; HUMAN; INFLAMMATION; INTESTINE BLOOD FLOW; MALE; OPHTHALMIC ARTERY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RETINA ARTERY; SKIN BLOOD FLOW; SUPERIOR MESENTERIC ARTERY;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; BLOOD FLOW VELOCITY; BLOOD VOLUME; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CILIARY ARTERIES; CROHN DISEASE; FEMALE; FIBRINOGEN; GASTROINTESTINAL AGENTS; HUMANS; LINEAR MODELS; MALE; MESENTERIC ARTERY, SUPERIOR; MIDDLE AGED; OPHTHALMIC ARTERY; PROSPECTIVE STUDIES; RETINAL ARTERY; TUMOR NECROSIS FACTOR-ALPHA; ULTRASONOGRAPHY, DOPPLER, COLOR; YOUNG ADULT;

EID: 84877073595     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2012.07.002     Document Type: Article

References (46)

1. Thornton M., Solomon M.J. Crohn's disease: in defense of a microvascular aetiology. Int J Colorectal Dis 2002, 17:287-297.
2. Carr N.D., Pullan B.R., Schofield P.F. Microvascular studies in nonspecific inflammatory bowel disease. Gut 1986, 27:542-549.
3. Brahme F., Lindström C. A comparative radiographic and pathological study of intestinal vasoarchitecture in Crohn's disease and ulcerative colitis. Gut 1970, 11:928-940.
4. Erikson U., Fagerberg S., Krause U., Olding L. Angiographic studies in Crohn's disease and in ulcerative colitis. AJR Am J Roentgenol 1970, 110:385-392.
5. Bousen E., Reuter S.R. Mesenteric angiography in the evaluation of inflammatory and neoplastic disease of intestine. Radiology 1966, 87:1028-1036.
6. Wakefield A.J., Sawyerr A.M., Dhillon A.P., Pittilo R.M., Rowles P.M., Lewis A.A., et al. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 1989, 2:1057-1062.
7. Kanazawa S., Tsunoda T., Onuma E., Majima T., Kagiyama M., Kikuchi K. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. Am J Gastroenterol 2001, 96:822-828.
8. Braegger C.P., Nicholls S., Murch S.H., Stephens S., MacDonald T.T. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 1992, 339:89-91.
9. Schreiber S., Nikolaus S., Hampe J. Activation of nuclear factor kappa B in inflammatory bowel disease. Gut 1998, 42:477-484.
10. Maconi G., Parente F., Bollani S., Imbesi V., Ardizzone S., Russo A., et al. Factors affecting splanchnic haemodynamics in Crohn's disease: a prospective controlled study using Doppler ultrasound. Gut 1998, 43:645-650.
11. van Oostayen J.A., Wasser M.N., van Hogezand R.A., Griffioen G., de Roos A. Activity of Crohn's disease assessed by measurement of superior mesenteric artery flow with Doppler US. Radiology 1994, 193:551-554.
12. van Oostayen J.A., Wasser M.N., van Hogezand R.A., Griffioen G., Biemond I., Lamers C.B., et al. Doppler sonography evaluation of superior mesenteric artery flow to assess Crohn's disease activity: correlation with clinical evaluation Crohn's disease activity index, and alpha1-antitrypsin clearance in feces. AJR Am J Roentgenol 1997, 168:429-433.
13. Ludwig D., Wiener S., Brüning A., Schwarting K., Jantschek G., Stange E.F. Mesenteric blood flow is related to disease activity and risk of relapse in Crohn's disease: a prospective follow-up study. Am J Gastroenterol 1999, 94:2942-2950.
14. Paredes J.M., Ripollés T., Cortés X., Martínez M.J., Barrachina M., Gómez F., et al. Abdominal sonographic changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's Disease. Dig Dis Sci 2010, 55:404-410.
15. van Oostayen J.A., Wasser M.N., Griffioen G., van Hogezand R.A., Lamers C.B., de Roos A. Diagnosis of Crohn's ileitis and monitoring of disease activity: value of Doppler ultrasound of superior mesenteric artery flow. Am J Gastroenterol 1998, 93:88-91.
16. D'Haens G.R., Panaccione R., Higgins P.D., Vermeire S., Gassull M., Chowers Y., et al. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?. Am J Gastroenterol 2011, 106:199-212.
17. Theodossiadis P.G., Markomichelakis N.N., Sfikakis P.P. Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation. Retina 2007, 27(4):399-413.
18. Best W.R., Becktel J.M., Singleton J.W., Kern F. Development of a Crohn's disease activity index. Gastroenterology 1976, 70:439-444.
19. Collins K.A., Korcarz C.E., Lang R.M. Use of echocardiography for the phenotypic assessment of genetically altered mice. Physiol Genomics 2003, 13:227-239.
20. Bonnin P., Pournaras J.A., Lazrak Z., Cohen S.Y., Legargasson J.F., Gaudric A., et al. Ultrasound assessment of early ocular vascular effects after intravitreal injection of bevacizumab (Avastin®) for neovascular age-related macular degeneration. Acta Ophthalmol 2010, 88:641-645.
21. British standards institution: precision of test method (BS5497, part 1) 1979, BSI, London.
22. Debbabi H., Bonnin P., Ducluzeau P.H., Lefthériotis G., Levy B.I. Non-invasive assessment of endothelial function in the skin microcirculation. Am J Hypertens 2010, 23:541-546.
23. Brown P.W., Bargen J.A., Weber H.M. Chronic inflammatory lesions of the small intestine (regional enteritis). Am J Dig Dis 1934, 1:426-431.
24. Warren S., Sommers S.C. Pathology of regional enteritis and ulcerative colitis. JAMA 1954, 154:189-193.
25. Hultén L., Lindhagen S., Lundgren O., Fasth S., Ahrén C. Regional intestinal blood flow in ulcerative colitis and Crohn's disease. Gastroenterology 1977, 72:388-396.
26. Meadows T.R., Batsakis J.G. Histopathological spectrum of regional enteritis. Arch Surg 1963, 87:976-981.
27. Brahme F. Mesenteric angiography in regional enterocolitis. Radiology 1966, 87:1037-1042.
28. McGovern V.J., Goulston S.J. Crohn's disease of the colon. Gut 1968, 9:164-176.
29. Perner A., Rask-Madsen J. Review article: the potential role of nitric oxide in chronic inflammatory bowel disorders. Aliment Pharmacol Ther 1999, 13:135-144.
30. Kimura H., Miura S., Shigematsu T., Ohkubo N., Tsuzuki Y., Kurose I., et al. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease. Dig Dis Sci 1997, 42:1047-1054.
31. Millar T.M., Stevens C.R., Benjamin N., Eisenthal R., Harrison R., Blake D.R. Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Lett 1998, 427:225-228.
32. Kanazawa S., Tsunoda T., Onuma E., Majima T., Kagiyama M., Kikuchi K. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. Am J Gastroenterol 2001, 96:822-828.
33. Nilsen E.M., Johansen F.E., Jahnsen F.L., Lundin K.E., Scholz T., Brandtzaeg P., et al. Cytokine profiles of cultured microvascular endothelial cells from the human intestine. Gut 1998, 42:635-642.
34. Yoshida H., Yilmaz C.E., Granger D.N. Role of tumor necrosis factor-α in the extraintestinal thrombosis associated with colonic inflammation. Inflamm Bowel Dis 2011, 17:2217-2223.
35. Rogler G., Andus T. Cytokines in inflammatory bowel disease. World J Surg 1998, 22:382-389.
36. Chiarantini E., Valanzano R., Liotta A.A., Cellai A.P., Fedi S., Ilari I., et al. Haemostatic abnormalities in inflammatory bowel disease. Thromb Res 1996, 82:137-146.
37. Targan S.R., Hanauer S.B., van Deventer S.J., Mayer L., Present D.H., Braakman T., et al. A short term study of chimeric monoclonal antibody cA2 to tumour necrosis factor alpha for Crohn's disease. Crohn's disease cA2 study group. N Engl J Med 1997, 337:1029-1035.
38. Powrie F., Leach M.W., Mauze S., Menon S., Caddle L.B., Coffman R.L. Inhibition of Th1 response prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ Tcells. Immunity 1994, 1:553-562.
39. Haber H.P., Busch A., Ziebach R., Stern M. Bowel wall thickness measured by ultrasound as a marker of Crohn's disease activity in children. Lancet 2000, 355:1239-1240.
40. Spalinger J., Patriquin H., Miron M.C., Marx G., Herzog D., Dubois J., et al. Doppler US in patients with Crohn disease: vessel density in the diseased bowel reflects disease activity. Radiology 2000, 217:787-791.
41. Borberg H., Tauchert M. Rheohaemapheresis of ophthalmological diseases and diseases of the microcirculation. Transfus Apher Sci 2006, 34:41-49.
42. Cruz B.A., Reis D.D., Araujo C.A. Minas Gerais Vasculitis Study Group. Refractory retinal vasculitis due to sarcoidosis successfully treated with infliximab. Rheumatol Int 2007, 27:1181-1183.
43. Theodossiadis P.G., Liarakos V.S., Sfikakis P.P., Charonis A., Agrogiannis G., Kavantzas N., et al. Intravitreal administration of the anti-TNF monoclonal antibody infliximab in the rabbit. Graefes Arch Clin Exp Ophthalmol 2009, 247:273-281.
44. Regatieri C.V., Dreyfuss J.L., Melo G.B., Lavinsky D., Farah M.E., Nader H.B. Dual role of intravitreous infliximab in experimental choroidal neovascularization: effect on the expression of sulfated lycosaminoglycans. Invest Ophthalmol Vis Sci 2009, 50:5487-5494.
45. Koizumi K., Poulaki V., Doehmen S., Welsandt G., Radetzky S., Lappas A., et al. Contribution of TNF-alpha to leukocyte adhesion, vascular leakage, and apoptotic cell death in endotoxin-induced uveitis in vivo. Invest Ophthalmol Vis Sci 2003, 44:2184-2191.
46. Weber P., Husemann S., Vielhaber H., Zimmer K.P., Nowak-Göttl U. Coagulation and fibrinolysis in children, adolescents, and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1999, 28:418-422.